Correction of temporal wasting using calcium hydroxylapatite with integral lidocaine: An underused procedure for enhancing overall facial appearance
Background Hollowing of the temple area is an early sign of aging that is often overlooked, but when corrected, can lead to significant subject and physician satisfaction. Aims To assess physician and subject awareness of the impact of temporal hollowing on appearance and to evaluate treatment satis...
Saved in:
Published in | Journal of cosmetic dermatology Vol. 20; no. 1; pp. 62 - 66 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
England
01.01.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
Hollowing of the temple area is an early sign of aging that is often overlooked, but when corrected, can lead to significant subject and physician satisfaction.
Aims
To assess physician and subject awareness of the impact of temporal hollowing on appearance and to evaluate treatment satisfaction following injection of calcium hydroxylapatite with integral lidocaine (CaHA(+)).
Patients/Methods
Subjects with temporal depression grade ≥2 on a validated Temple Hollowing Scale were recruited. CaHA(+) was injected supraperiosteally using a bolus technique. Photographs were taken prior to treatment and 30 days, and graded by three evaluating physicians using the Global Aesthetic Improvement Scale (GAIS) and Temple Hollowing Scale. The same physicians estimated subjects' age before and after treatment. Photographs were graded by patients as part of a satisfaction questionnaire.
Results
The study enrolled 10 subjects aged 32‐68 years old. Physician GAIS scores of subject appearance at 1 month were rated as “very much improved” in 80% and “much improved” in 20% of subjects. Temple hollows were graded as 1 after treatment in 90% of subjects. Following blinded review of patients' true ages, estimates for subjects' perceived age were on average 4 years younger than their actual age. Most subjects had not been aware of temple hollowing prior to treatment, but nine out of 10 were very to extremely satisfied with results, and all were willing to repeat treatment. No treatment complications were observed.
Conclusion
Treatment of the temple area can have a dramatic aesthetic effect and should not be neglected when addressing facial rejuvenation. CaHA(+) is an effective and well‐tolerated product for use in the temple area and is associated with a high degree of subject and physician satisfaction. |
---|---|
AbstractList | Hollowing of the temple area is an early sign of aging that is often overlooked, but when corrected, can lead to significant subject and physician satisfaction.BACKGROUNDHollowing of the temple area is an early sign of aging that is often overlooked, but when corrected, can lead to significant subject and physician satisfaction.To assess physician and subject awareness of the impact of temporal hollowing on appearance and to evaluate treatment satisfaction following injection of calcium hydroxylapatite with integral lidocaine (CaHA(+)).AIMSTo assess physician and subject awareness of the impact of temporal hollowing on appearance and to evaluate treatment satisfaction following injection of calcium hydroxylapatite with integral lidocaine (CaHA(+)).Subjects with temporal depression grade ≥2 on a validated Temple Hollowing Scale were recruited. CaHA(+) was injected supraperiosteally using a bolus technique. Photographs were taken prior to treatment and 30 days, and graded by three evaluating physicians using the Global Aesthetic Improvement Scale (GAIS) and Temple Hollowing Scale. The same physicians estimated subjects' age before and after treatment. Photographs were graded by patients as part of a satisfaction questionnaire.PATIENTS/METHODSSubjects with temporal depression grade ≥2 on a validated Temple Hollowing Scale were recruited. CaHA(+) was injected supraperiosteally using a bolus technique. Photographs were taken prior to treatment and 30 days, and graded by three evaluating physicians using the Global Aesthetic Improvement Scale (GAIS) and Temple Hollowing Scale. The same physicians estimated subjects' age before and after treatment. Photographs were graded by patients as part of a satisfaction questionnaire.The study enrolled 10 subjects aged 32-68 years old. Physician GAIS scores of subject appearance at 1 month were rated as "very much improved" in 80% and "much improved" in 20% of subjects. Temple hollows were graded as 1 after treatment in 90% of subjects. Following blinded review of patients' true ages, estimates for subjects' perceived age were on average 4 years younger than their actual age. Most subjects had not been aware of temple hollowing prior to treatment, but nine out of 10 were very to extremely satisfied with results, and all were willing to repeat treatment. No treatment complications were observed.RESULTSThe study enrolled 10 subjects aged 32-68 years old. Physician GAIS scores of subject appearance at 1 month were rated as "very much improved" in 80% and "much improved" in 20% of subjects. Temple hollows were graded as 1 after treatment in 90% of subjects. Following blinded review of patients' true ages, estimates for subjects' perceived age were on average 4 years younger than their actual age. Most subjects had not been aware of temple hollowing prior to treatment, but nine out of 10 were very to extremely satisfied with results, and all were willing to repeat treatment. No treatment complications were observed.Treatment of the temple area can have a dramatic aesthetic effect and should not be neglected when addressing facial rejuvenation. CaHA(+) is an effective and well-tolerated product for use in the temple area and is associated with a high degree of subject and physician satisfaction.CONCLUSIONTreatment of the temple area can have a dramatic aesthetic effect and should not be neglected when addressing facial rejuvenation. CaHA(+) is an effective and well-tolerated product for use in the temple area and is associated with a high degree of subject and physician satisfaction. Background Hollowing of the temple area is an early sign of aging that is often overlooked, but when corrected, can lead to significant subject and physician satisfaction. Aims To assess physician and subject awareness of the impact of temporal hollowing on appearance and to evaluate treatment satisfaction following injection of calcium hydroxylapatite with integral lidocaine (CaHA(+)). Patients/Methods Subjects with temporal depression grade ≥2 on a validated Temple Hollowing Scale were recruited. CaHA(+) was injected supraperiosteally using a bolus technique. Photographs were taken prior to treatment and 30 days, and graded by three evaluating physicians using the Global Aesthetic Improvement Scale (GAIS) and Temple Hollowing Scale. The same physicians estimated subjects' age before and after treatment. Photographs were graded by patients as part of a satisfaction questionnaire. Results The study enrolled 10 subjects aged 32‐68 years old. Physician GAIS scores of subject appearance at 1 month were rated as “very much improved” in 80% and “much improved” in 20% of subjects. Temple hollows were graded as 1 after treatment in 90% of subjects. Following blinded review of patients' true ages, estimates for subjects' perceived age were on average 4 years younger than their actual age. Most subjects had not been aware of temple hollowing prior to treatment, but nine out of 10 were very to extremely satisfied with results, and all were willing to repeat treatment. No treatment complications were observed. Conclusion Treatment of the temple area can have a dramatic aesthetic effect and should not be neglected when addressing facial rejuvenation. CaHA(+) is an effective and well‐tolerated product for use in the temple area and is associated with a high degree of subject and physician satisfaction. Hollowing of the temple area is an early sign of aging that is often overlooked, but when corrected, can lead to significant subject and physician satisfaction. To assess physician and subject awareness of the impact of temporal hollowing on appearance and to evaluate treatment satisfaction following injection of calcium hydroxylapatite with integral lidocaine (CaHA(+)). Subjects with temporal depression grade ≥2 on a validated Temple Hollowing Scale were recruited. CaHA(+) was injected supraperiosteally using a bolus technique. Photographs were taken prior to treatment and 30 days, and graded by three evaluating physicians using the Global Aesthetic Improvement Scale (GAIS) and Temple Hollowing Scale. The same physicians estimated subjects' age before and after treatment. Photographs were graded by patients as part of a satisfaction questionnaire. The study enrolled 10 subjects aged 32-68 years old. Physician GAIS scores of subject appearance at 1 month were rated as "very much improved" in 80% and "much improved" in 20% of subjects. Temple hollows were graded as 1 after treatment in 90% of subjects. Following blinded review of patients' true ages, estimates for subjects' perceived age were on average 4 years younger than their actual age. Most subjects had not been aware of temple hollowing prior to treatment, but nine out of 10 were very to extremely satisfied with results, and all were willing to repeat treatment. No treatment complications were observed. Treatment of the temple area can have a dramatic aesthetic effect and should not be neglected when addressing facial rejuvenation. CaHA(+) is an effective and well-tolerated product for use in the temple area and is associated with a high degree of subject and physician satisfaction. |
Author | Barbarino, Sheila C. |
Author_xml | – sequence: 1 givenname: Sheila C. orcidid: 0000-0002-8367-8663 surname: Barbarino fullname: Barbarino, Sheila C. email: sheila.barbarino@gmail.com organization: Barbarino Surgical Arts |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32441877$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kctu3CAUhlGVqrm0mz5AxDKqNAkYg-3sommbiyJlk66tM3CcIcLgAO503qMPXLuTZlFFYQFIfN-vI_5DsueDR0I-c3bKp3X2GLQ55UIy-Y4c8LISi4IrufdyF2yfHKb0yBivGi4_kH1RlCWvq-qA_F6GGFFnGzwNHc3YDyGCoxtI2foHOqZ51-C0HXu63poYfm0dDJBtRrqxeU2tz_gwO86aoMF6PKcXno7eYBwTGjrEoNGMEWkXIkW_Bq_n1PATJ83RDrSddBgGhDi94UfyvgOX8NPzeUR-fP92v7xa3N5dXi8vbhdaFI1cGLXiqlaSq5U2FdRGKcNk2ehC1FBrZNA1qtSyKSXvmsoU0HHRiNIUqpEGlDgiJ7vcacKnEVNue5s0Ogcew5jaomRKsLpSfEKPn9Fx1aNph2h7iNv2309OwJcdoGNIKWL3gnDWzjW1c03t35ommP0Ha5thLiFHsO51he-UjXW4fSO8vblbft05fwDr_6fc |
CitedBy_id | crossref_primary_10_1093_asj_sjab035 crossref_primary_10_3390_jcm13061686 crossref_primary_10_1111_jocd_16450 crossref_primary_10_3390_cosmetics11050165 crossref_primary_10_1097_GOX_0000000000006400 crossref_primary_10_1007_s00266_024_04429_9 |
Cites_doi | 10.1097/01.prs.0000234847.36020.52 10.1097/PRS.0b013e31824a2e21 10.1177/1090820X10391214 10.1111/dsu.12362 10.1016/j.ejfs.2014.07.006 10.1016/j.cps.2012.09.001 10.1097/DSS.0000000000001268 10.1097/DSS.0000000000000848 10.1111/jocd.12437 10.1177/1090820X10374099 10.1055/s-0036-1586497 10.1097/PRS.0000000000001752 10.1111/j.1468-3083.2006.01518.x |
ContentType | Journal Article |
Copyright | 2020 Wiley Periodicals LLC 2020 Wiley Periodicals LLC. |
Copyright_xml | – notice: 2020 Wiley Periodicals LLC – notice: 2020 Wiley Periodicals LLC. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1111/jocd.13505 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1473-2165 |
EndPage | 66 |
ExternalDocumentID | 32441877 10_1111_jocd_13505 JOCD13505 |
Genre | article Journal Article |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 1OC 24P 29K 31~ 33P 36B 3SF 4.4 50Y 50Z 52M 52O 52T 52U 52V 52W 53G 5GY 5HH 5VS 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 8FI 8FJ 930 A01 A03 AAESR AAEVG AAHHS AAKAS AANHP AAONW AASGY AAXRX AAZKR ABCUV ABDBF ABJNI ABPVW ABUWG ABXGK ACAHQ ACBWZ ACCFJ ACCMX ACCZN ACGFS ACMXC ACPOU ACRPL ACUHS ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADPDF ADXAS ADZCM ADZMN AEEZP AEGXH AEIMD AENEX AEQDE AEUQT AFBPY AFEBI AFGKR AFKRA AFPWT AFZJQ AIACR AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BENPR BFHJK BHBCM BMXJE BROTX BRXPI C45 CAG CCPQU COF CS3 D-6 D-7 D-E D-F D-I DCZOG DPXWK DRFUL DRMAN DRSTM EAD EAP EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F21 F5P FEDTE FUBAC FYUFA G-S G.N GODZA H.X HF~ HMCUK HVGLF HZ~ IHE KBYEO LATKE LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ N04 N05 NF~ O66 O9- OIG OVD OVEED P2P P2W P2X P2Z P4B P4D PIMPY Q.N QB0 R.K ROL RX1 SUPJJ SV3 TEORI TUS UB1 UKHRP V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WVDHM YFH YUY ZZTAW ~IA ~WT AAYXX AGQPQ CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7X8 AAMMB AEFGJ AGXDD AIDQK AIDYY |
ID | FETCH-LOGICAL-c3295-d6b1686516bcd7a8d66d0549c238a8ce0af964c59451f97d2af13934d2695da63 |
ISSN | 1473-2130 1473-2165 |
IngestDate | Fri Jul 11 04:31:01 EDT 2025 Wed Feb 19 02:29:43 EST 2025 Thu Apr 24 22:51:36 EDT 2025 Tue Jul 01 02:37:35 EDT 2025 Wed Jan 22 16:30:55 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | facial rejuvenation aging calcium hydroxylapatite temple area lidocaine |
Language | English |
License | 2020 Wiley Periodicals LLC. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c3295-d6b1686516bcd7a8d66d0549c238a8ce0af964c59451f97d2af13934d2695da63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-8367-8663 |
PMID | 32441877 |
PQID | 2406308761 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_2406308761 pubmed_primary_32441877 crossref_primary_10_1111_jocd_13505 crossref_citationtrail_10_1111_jocd_13505 wiley_primary_10_1111_jocd_13505_JOCD13505 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | January 2021 2021-01-00 2021-Jan 20210101 |
PublicationDateYYYYMMDD | 2021-01-01 |
PublicationDate_xml | – month: 01 year: 2021 text: January 2021 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Journal of cosmetic dermatology |
PublicationTitleAlternate | J Cosmet Dermatol |
PublicationYear | 2021 |
References | 2018; 17 2015; 5 2006; 20 2013; 39 2015; 136 2013; 12 2013; 40 2011; 31 2016; 32 2016; 42 2018; 44 2006; 118 2015; 8 2016; 15 2010; 30 2012; 129 e_1_2_7_6_1 e_1_2_7_5_1 Meland M (e_1_2_7_17_1) 2016; 15 e_1_2_7_4_1 e_1_2_7_9_1 e_1_2_7_7_1 e_1_2_7_18_1 Lupo MP (e_1_2_7_3_1) 2016; 15 Moradi A (e_1_2_7_8_1) 2013; 12 e_1_2_7_16_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_14_1 e_1_2_7_13_1 e_1_2_7_12_1 e_1_2_7_10_1 Van Loghem JV (e_1_2_7_19_1) 2015; 8 Pavicic T (e_1_2_7_11_1) 2013; 12 |
References_xml | – volume: 136 start-page: 44S issue: 5 suppl year: 2015 end-page: 48S article-title: Newer understanding of specific anatomic targets in the aging face as applied to injectables: aging changes in the craniofacial skeleton and facial ligaments publication-title: Plast Reconstr Surg – volume: 39 start-page: 1895 issue: 12 year: 2013 end-page: 1902 article-title: Quantifying soft tissue loss in facial aging: a study in women using magnetic resonance imaging publication-title: Dermatol Surg – volume: 40 start-page: 77 year: 2013 end-page: 89 article-title: Esthetic rejuvenation of the temple publication-title: Clin Plast Surg – volume: 20 start-page: 17 issue: suppl 1 year: 2006 end-page: 21 article-title: Poly‐L‐lactic acid: consultation on the injection techniques publication-title: J Eur Acad Dermatol Venereol – volume: 31 start-page: 89 year: 2011 end-page: 94 article-title: A technique for filling the temples with highly diluted hyaluronic acid: the “dilution solution” publication-title: Aesthet Surg J – volume: 5 start-page: 46 issue: 2 year: 2015 end-page: 56 article-title: Analysis of facial soft tissue changes with aging and their effects on facial morphology: a forensic perspective publication-title: Egypt J Foren Sci – volume: 12 start-page: 470 issue: 4 year: 2013 end-page: 475 article-title: A 12‐month, prospective, evaluator‐blinded study of small gel particle hyaluronic acid filler in the correction of temporal fossa volume loss publication-title: J Drugs Dermatol – volume: 12 start-page: 996 year: 2013 end-page: 1002 article-title: Calcium hydroxylapatite filler: an overview of safety and tolerability publication-title: J Drugs Dermatol – volume: 30 start-page: 428 year: 2010 end-page: 433 article-title: Orbitofacial rejuvenation of temple hollowing with Perlane injectable filler publication-title: Aesthet Surg J – volume: 118 start-page: 34S year: 2006 end-page: 45S article-title: Prospective, open‐label, 18‐month trial of calcium hydroxylapatite (Radiesse) for facial soft‐tissue augmentation in patients with human immunodeficiency virus‐associated lipoatrophy: one year durability publication-title: Plast Reconstr Surg – volume: 17 start-page: 39 issue: 1 year: 2018 end-page: 46 article-title: Sensitivity of aspiration as a safety test before injection of soft tissue fillers publication-title: J Cosmet Dermatol – volume: 129 start-page: 1200 year: 2012 end-page: 1207 article-title: A guide to interpreting a study of patient‐reported outcomes publication-title: Plast Reconstr Surg – volume: 15 start-page: 1107 issue: 9 year: 2016 end-page: 1110 article-title: Rheological properties of calcium hydroxylapatite with integral lidocaine publication-title: J Drugs Dermatol – volume: 44 start-page: 93 issue: 1 year: 2018 end-page: 100 article-title: Pilot study examining the safety and efficacy of calcium hydroxylapatite filler with integral lidocaine over a 12‐month period to correct temporal fossa volume loss publication-title: Dermatol Surg – volume: 42 start-page: S203 year: 2016 end-page: S210 article-title: Development and validation of a photonumeric scale for evaluation of volume deficit of the temple publication-title: Dermatol Surg – volume: 15 start-page: 1151 issue: 9 year: 2016 end-page: 1157 article-title: Tox outside the box: off‐label aesthetic uses of botulinum toxin publication-title: J Drugs Dermatol – volume: 32 start-page: 520 issue: 5 year: 2016 end-page: 531 article-title: Solid implants in facial plastic surgery: potential complications and how to prevent them publication-title: Facial Plast Surg – volume: 8 start-page: 38 issue: 1 year: 2015 end-page: 49 article-title: Calcium hydroxylapatite: over a decade of clinical experience publication-title: J Clin Aesthet Dermatol – volume: 12 start-page: 470 issue: 4 year: 2013 ident: e_1_2_7_8_1 article-title: A 12‐month, prospective, evaluator‐blinded study of small gel particle hyaluronic acid filler in the correction of temporal fossa volume loss publication-title: J Drugs Dermatol – ident: e_1_2_7_12_1 doi: 10.1097/01.prs.0000234847.36020.52 – ident: e_1_2_7_16_1 doi: 10.1097/PRS.0b013e31824a2e21 – ident: e_1_2_7_7_1 doi: 10.1177/1090820X10391214 – volume: 8 start-page: 38 issue: 1 year: 2015 ident: e_1_2_7_19_1 article-title: Calcium hydroxylapatite: over a decade of clinical experience publication-title: J Clin Aesthet Dermatol – ident: e_1_2_7_15_1 doi: 10.1111/dsu.12362 – ident: e_1_2_7_4_1 doi: 10.1016/j.ejfs.2014.07.006 – ident: e_1_2_7_5_1 doi: 10.1016/j.cps.2012.09.001 – ident: e_1_2_7_13_1 doi: 10.1097/DSS.0000000000001268 – ident: e_1_2_7_14_1 doi: 10.1097/DSS.0000000000000848 – ident: e_1_2_7_18_1 doi: 10.1111/jocd.12437 – volume: 15 start-page: 1151 issue: 9 year: 2016 ident: e_1_2_7_3_1 article-title: Tox outside the box: off‐label aesthetic uses of botulinum toxin publication-title: J Drugs Dermatol – volume: 12 start-page: 996 year: 2013 ident: e_1_2_7_11_1 article-title: Calcium hydroxylapatite filler: an overview of safety and tolerability publication-title: J Drugs Dermatol – volume: 15 start-page: 1107 issue: 9 year: 2016 ident: e_1_2_7_17_1 article-title: Rheological properties of calcium hydroxylapatite with integral lidocaine publication-title: J Drugs Dermatol – ident: e_1_2_7_6_1 doi: 10.1177/1090820X10374099 – ident: e_1_2_7_10_1 doi: 10.1055/s-0036-1586497 – ident: e_1_2_7_2_1 doi: 10.1097/PRS.0000000000001752 – ident: e_1_2_7_9_1 doi: 10.1111/j.1468-3083.2006.01518.x |
SSID | ssj0017915 |
Score | 2.2466385 |
Snippet | Background
Hollowing of the temple area is an early sign of aging that is often overlooked, but when corrected, can lead to significant subject and physician... Hollowing of the temple area is an early sign of aging that is often overlooked, but when corrected, can lead to significant subject and physician... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 62 |
SubjectTerms | Adult Aged aging Calcium calcium hydroxylapatite Child, Preschool Cosmetic Techniques Durapatite facial rejuvenation Humans Lidocaine Middle Aged Patient Satisfaction Skin Aging temple area Treatment Outcome |
Title | Correction of temporal wasting using calcium hydroxylapatite with integral lidocaine: An underused procedure for enhancing overall facial appearance |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjocd.13505 https://www.ncbi.nlm.nih.gov/pubmed/32441877 https://www.proquest.com/docview/2406308761 |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9NAFB6FVkJcEDth0yC4gOUq3sY2tyoNqiqVHmhRb9Z4FiWSa0dNDIIDv4IfzHue8SRpCipcLGvk_X1--0LIWx0rrUWkfBlr5cdZoP1SR6HPBajXLFdxWGKB8_EndngWH50n54PBz_XqkmW5J35cW1fyP1SFNaArVsn-A2XdRWEB9oG-sAUKw_ZGNB7jaA3R63y2y1TlfeOLLpm5NRW1vBKz9sKbfpeYslJxzKFeKuOBtd0iKq-aSZBq2HXUeAqxtuyyXSjsIgAiTmKcoesOXk-xQwemSn9Fd1aFE3vQ687nc_hpHIa29V3RLC6wYtKTKAyWG-58E_WYdWPAvc9TNau4N95b90iEwZpHwjDROI38MLDxFrW-ZuZC9Jw3HG0hzLBRy6CNQDZTWf7E6hshcXbHKFkJtD6If0XOuexDZ_fAuUV37i2yG4KZAXxy9-TLZHLg4lBp3s3AcG9kG9x2uWDuzpsqzZadsmn2dHrL6T1y1xKA7hv03CcDVT8gt49tSsVD8msFItpo2oOIWhDRDkTUgoheARFFENEeRNSB6APdr6mDEHUQogAh6iBELYSogRBdQegROfs4OR0f-nZUhy-iME98ycqAZSwJWClkyjPJmARjIBegEfJMqBHXOYtFksdJoPNUhlyD6RHFMmR5IjmLHpOduqnVU0LLUguRMhzcir4blTNgHkkqI52JMtHpkLzrv3YhbB97HKdSFdt0HZI37ti56d5y7VGve6IVwFwxYsZr1bSLAtVdbJnJgiF5YqjprgOWSBxkKTzP-468f7lBcXQyPuj2nt3ogZ6TO6v_6gXZWV626iXovsvylQXob3mRuFo |
linkProvider | Ovid |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Correction+of+temporal+wasting+using+calcium+hydroxylapatite+with+integral+lidocaine%3A+An+underused+procedure+for+enhancing+overall+facial+appearance&rft.jtitle=Journal+of+cosmetic+dermatology&rft.au=Barbarino%2C+Sheila+C.&rft.date=2021-01-01&rft.issn=1473-2130&rft.eissn=1473-2165&rft.volume=20&rft.issue=1&rft.spage=62&rft.epage=66&rft_id=info:doi/10.1111%2Fjocd.13505&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_jocd_13505 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1473-2130&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1473-2130&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1473-2130&client=summon |